China RuiTai International Holdings Retains CCG Elite for Investor Relation... (l that acts as a thickener and dissolves...)

China RuiTai International Holdings Retains CCG Elite for Investor Relations Services

Date:3/25/2008

l that acts as a thickener and dissolves in water and other organic solvents. The Company is one of the largest non-ionic cellulose ether producers in China delivering products for the pharmaceutical, PVC manufacturing, construction industry, the personal care market and oil field exploration and recovery industries. China RuiTai exports to United States, Europe, India, the Middle East, and South East Asia.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: This press release contains certain "forward-looking statements," as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors include, but are not limited to the Company's ability to complete product orders, coordinate product design with its customers, ability to expand and grow its distribution channels, political and economic factors in the People's Republic of China, the Company's ability to find attractive acquisition candidates, dependence on a limited number of larger customers and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:

CCG Elite Investor Relations

Crocker Coulson, President

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

0

GOOD

Page: 1 2 3
Related medicine news :

1. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
2. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
3. China Nepstar Chain Drugstore Announces Dividend
4. Alsius Corporation Receives Regulatory Approval in China and Mexico
5. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
6. China Nepstar Chain Drugstore Reports 231.5% Increase in Net Income and Record Gross Margin of 48.5% for Fourth Quarter 2007
7. Flagship Global Health and China HealthCare Holdings Form Strategic Alliance
8. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
9. China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19
10. Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
11. Smoking is major risk factor for stroke in China

Post Your Comments:

China RuiTai International Holdings Retains CCG Elite for Investor Relation...(l that acts as a thickener and dissolves...),Health